Peer Reviewed
Drug update

Budesonide/eformoterol combination inhaler as maintenance and reliever treatment in asthma

Matthew Peters
Abstract
For patients with significant asthma, the use of budesonide/eformoterol as both maintenance and reliever treatment is similarly effective to other management strategies in the achievement of good asthma control, while also reducing episodes of poor control and lessening overall treatment burden.
Key Points

    There is now convincing evidence that the combination inhaler (budesonide/eformoterol) can be used as both maintenance and reliever therapy in patients with asthma, improving symptom control and lung function and reducing the risk of severe exacerbations.

Get full access
Subscribe for full access to all articles
Buy this article

Single article purchases are temporarily unavailable due to site maintenance.

If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.

Thank you for your patience and understanding.

Already a subscriber?